ARCE therapeutics, Inc. is a privately-held company that was found in Feb. 2020 as a discovery to clinical-stage biotech company, developing proprietary genetic technologies in immune cell engineering, followed by clinical trials and eventual commercialization of cell therapies to market.

ARCE therapeutics, Inc. is developing first-in-class & best-in-class CAR-T cell therapy with proprietary technologies for the treatment of various forms of cancers, including hematological cancers and solid tumors in human patients.